Erudio Healtherudio.com
Sponsor
Akeso trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Akeso yet. Erudio has found public clinician commentary on 5 clinical trials sponsored by Akeso, including HARMONi-6, HARMONi-A, HARMONi-GI1 and NCT05227664. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Akeso). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| HARMONi-6 NCT05840016 · Akeso DeepView → | first-line advanced squamous non-small cell lung cancer | Phase 3 | Deep | View | |||
| HARMONi-GI1 NCT06591520 · Akeso DeepView → | first-line advanced biliary tract cancer | Phase 3 | Deep | View | |||
| NCT05227664 NCT05227664 · Akeso FocusedView → | untreated locally advanced or metastatic triple-negative breast cancer | Phase 2 | Focused | View | |||
| HARMONi-A NCT05184712 · Akeso FocusedView → | EGFR-mutant locally advanced or metastatic non-squamous NSCLC | Phase 3 | Focused | View | |||
| HARMONi-2 NCT05499390 · Akeso FocusedView → | first-line PD-L1-positive advanced non-small cell lung cancer | Phase 3 | Focused | View | |||